文献速递流行病学与生物统计

难民与寻求庇护者精神疾病患病率:系统综述与荟萃分析

The prevalence of mental illness in refugees and asylum seekers: A systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2020-09-21

结果显示PTSD患病率为31.46%(95%CI 24.43-38.5),抑郁为31.5%(95%CI 22.64-40.38),焦虑障碍为11%(95%CI 6.75-15.43),精神病性障碍为1.51%(95%CI 0.63-2.40)。结论指出难民与寻求庇护者PTSD和抑郁患病率高且持续,需长期精神卫生照护。

要点

  • 难民与寻求庇护者PTSD患病率31.46%,抑郁31.5%,均处高位。
  • 焦虑障碍患病率11%,精神病性障碍仅1.51%。
  • 需在安置初期之后持续提供长期精神卫生照护。

核心结论

  • 难民与寻求庇护者PTSD和抑郁患病率高且持续,需超越安置初期的长期精神卫生照护。

研究设计与样本

  • 纳入标准要求精神疾病诊断涉及临床访谈和 validated 评估工具,且报告至少50名参与者;采用随机效应模型基于逆方差权重合并,并按性别、样本量、流离失所时长、签证状态、原籍国、当前居住地、访谈类型和诊断工具进行亚组分析。
  • 系统综述注册于PROSPERO(CRD42016046349)。

主要发现

  • PTSD患病率为31.46%(95%CI 24.43-38.5)。
  • 抑郁患病率为31.5%(95%CI 22.64-40.38)。
  • 焦虑障碍患病率为11%(95%CI 6.75-15.43)。
  • 精神病性障碍患病率为1.51%(95%CI 0.63-2.40)。

关键数值与推荐

  • PTSD患病率31.46%(95%CI 24.43-38.5),抑郁患病率31.5%(95%CI 22.64-40.38)。
  • 焦虑障碍患病率11%(95%CI 6.75-15.43),精神病性障碍患病率1.51%(95%CI 0.63-2.40)。
  • 诊断需基于临床访谈和 validated 评估工具,且研究至少报告50名参与者。

临床怎么用

  • 筛查与诊疗应覆盖PTSD、抑郁、焦虑和精神病性障碍,不应仅关注PTSD。
  • 对难民与寻求庇护者应规划长期精神卫生照护,延伸至安置初期之后。

局限性

  • PTSD、抑郁和焦虑患病率估计存在显著异质性。
  • 纳入研究报告的协变量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Globally, the number of refugees and asylum seekers has reached record highs. Past research in refugee mental health has reported wide variation in mental illness prevalence data, partially attributable to methodological limitations. This systematic review aims to summarise the current body of evidence for the prevalence of mental illness in global refugee populations and overcome methodological limitations of individual studies. METHODS AND FINDINGS: A comprehensive search of electronic databases was undertaken from 1 January 2003 to 4 February 2020 (MEDLINE, MEDLINE In-Process, EBM Reviews, Embase, PsycINFO, CINAHL, PILOTS, Web of Science). Quantitative studies were included if diagnosis of mental illness involved a clinical interview and use of a validated assessment measure and reported at least 50 participants. Study quality was assessed using a descriptive approach based on a template according to study design (modified Newcastle-Ottawa Scale). Random-effects models, based on inverse variance weights, were conducted. Subgroup analyses were performed for sex, sample size, displacement duration, visa status, country of origin, current residence, type of interview (interpreter-assisted or native language), and diagnostic measure. The systematic review was registered with PROSPERO (CRD) 42016046349. The search yielded a result of 21,842 records. Twenty-six studies, which included one randomised controlled trial and 25 observational studies, provided results for 5,143 adult refugees and asylum seekers. Studies were undertaken across 15 countries: Australia (652 refugees), Austria (150), China (65), Germany (1,104), Italy (297), Lebanon (646), Nepal (574), Norway (64), South Korea (200), Sweden (86), Switzerland (164), Turkey (238), Uganda (77), United Kingdom (420), and the United States of America (406). The prevalence of posttraumatic stress disorder (PTSD) was 31.46% (95% CI 24.43-38.5), the prevalence of depression was 31.5% (95% CI 22.64-40.38), the prevalence of anxiety disorders was 11% (95% CI 6.75-15.43), and the prevalence of psychosis was 1.51% (95% CI 0.63-2.40). A limitation of the study is that substantial heterogeneity was present in the prevalence estimates of PTSD, depression, and anxiety, and limited covariates were reported in the included studies. CONCLUSIONS: This comprehensive review generates current prevalence estimates for not only PTSD but also depression, anxiety, and psychosis. Refugees and asylum seekers have high and persistent rates of PTSD and depression, and the results of this review highlight the need for ongoing, long-term mental health care beyond the initial period of resettlement.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Blackmore R, Boyle JA, Fazel M, et al. The prevalence of mental illness in refugees and asylum seekers: A systematic review and meta-analysis. PLoS Med. 2020. PMID: 32956381. doi:10.1371/journal.pmed.1003337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。